| NCT ID | NCT06322433 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Auxologico Italiano |
| Condition | Pathologic Myopia |
| Study Type | OBSERVATIONAL |
| Enrollment | 138 participants |
| Start Date | 2023-11-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 138 participants in total. It began in 2023-11-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this non-interventional retrospective and prospective observational study, the long-term evolution of clinical and iconographic characteristics of patients with pathological myopia will be considered Changes of some specific clinical, tomographic and angiographic variables evaluated on the baseline and after a minimum of 5 years follow-up will be studied.
Eligibility Criteria
Inclusion Criteria: \- high myopia Exclusion Criteria: * acute ischemic optic neuropathy * macular and peripapillary atrophy * other forms of maculopathy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06322433 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pathologic Myopia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06322433 currently recruiting?
Yes, NCT06322433 is actively recruiting participants. Contact the research team at dottpaolomilani@hotmail.com for enrollment information.
Where is the NCT06322433 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06322433 clinical trial?
NCT06322433 is sponsored by Istituto Auxologico Italiano. The trial plans to enroll 138 participants.